What is the prevalence of Microvillus Inclusion Disease?
How many people does Microvillus Inclusion Disease affect? Does it have the same prevalence in men and women? And in the different countries?
Microvillus Inclusion Disease (MVID) is a rare genetic disorder characterized by severe diarrhea and malabsorption in infants. It is estimated to affect approximately 1 in 50,000 to 100,000 live births worldwide. MVID is typically diagnosed within the first few days or weeks of life and requires lifelong management. The condition is caused by mutations in specific genes involved in the formation and function of microvilli in the small intestine. Early diagnosis and appropriate medical interventions are crucial for improving the prognosis and quality of life for individuals with MVID.
Microvillus Inclusion Disease (MVID) is a rare genetic disorder that affects the functioning of the intestines. It is characterized by severe diarrhea, malabsorption, and failure to thrive in affected infants. MVID is an autosomal recessive disorder, meaning that both parents must carry a mutated gene for their child to be affected.
Due to its rarity, the prevalence of Microvillus Inclusion Disease is relatively low. Exact figures are challenging to determine as it is often underdiagnosed or misdiagnosed. However, studies estimate that MVID affects approximately 1 in every 50,000 to 100,000 live births worldwide.
Infants with MVID typically present with symptoms within the first few days or weeks of life. The chronic diarrhea associated with the condition can lead to dehydration, electrolyte imbalances, and nutrient deficiencies. Early diagnosis and appropriate management are crucial for the long-term health and survival of affected individuals.
While the prevalence of Microvillus Inclusion Disease is relatively low, it is essential for healthcare professionals to be aware of this condition to ensure timely diagnosis and appropriate interventions for affected infants.
